Berberine 500 mg
Withdrawn from the US market on 26 September 2023 (according to the DSLD)
Wonder Labs, food supplement from the US market
Label withdrawn from the US market. Berberine 500 mg (Wonder Labs), a food supplement au code-barres 099528874606, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 72 µg a day according to the label (at most 1 serving a day), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Wonder Labs
- Barcode
- 099528874606
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Gelatin, Vegetable Magnesium Stearate, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Chromium | Mineral | 72 µg |
| Berberine HCl | Other substance | 500 mg |
| Cinnamon (Cinnamomum cassia) | Plant | 334 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Berberine 500 mg
Entered into DSLD on 23 August 2023. On sale on the US market (according to the DSLD).- Same quantity, different name: Berberine Hydrochloride in this version; Berberine HCl on the displayed label (500 mg)
- Same quantity, different name: ChromeMate in this version; Chromium on the displayed label (72 mcg)
- Different quantity per serving : Cinnamon: 250 mg in this version; 334 mg on the displayed label
Official label: Berberine 500 mg
Entered into DSLD on 11 April 2022. Withdrawn from the US market on 26 September 2023 (according to the DSLD).Same active composition.
Official label: Berberine 500 mg
Entered into DSLD on 22 January 2022. On sale on the US market (according to the DSLD).Same active composition.
Official label: Berberine 500 mg
Entered into DSLD on 22 January 2022. Withdrawn from the US market on 26 September 2023 (according to the DSLD).Same active composition.
Official label: Berberine 500 mg
Entered into DSLD on 22 January 2022. Withdrawn from the US market on 26 September 2023 (according to the DSLD).Same active composition.
Official label: Berberine 500 mg
Entered into DSLD on 22 January 2022. Withdrawn from the US market on 24 October 2022 (according to the DSLD).- Same quantity, different name: Chromate in this version; Chromium on the displayed label (72 mcg)
Official label: Berberine 500 mg
Entered into DSLD on 22 January 2022. Withdrawn from the US market on 26 September 2023 (according to the DSLD).Same active composition.
Official label: Berberine 500 mg
Entered into DSLD on 18 December 2021. On sale on the US market (according to the DSLD).Same active composition.
Official label: Berberine 500 mg
Entered into DSLD on 18 December 2021. Withdrawn from the US market on 26 September 2023 (according to the DSLD).Same active composition.
Official label: Berberine 500 mg
Entered into DSLD on 19 November 2021. Withdrawn from the US market on 26 September 2023 (according to the DSLD).- Same quantity, different name: Berberine Hydrochloride in this version; Berberine HCl on the displayed label (500 mg)
Older versions (3)
Official label: Berberine 500 mg
Entered into DSLD on 19 November 2021. Withdrawn from the US market on 24 August 2021 (according to the DSLD).Same active composition.
Official label: Berberine 500 mg
Entered into DSLD on 19 November 2021. Withdrawn from the US market on 24 August 2021 (according to the DSLD).Same active composition.
Official label: Berberine 500 mg
Entered into DSLD on 19 November 2021. Withdrawn from the US market on 26 September 2023 (according to the DSLD).Same active composition.
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Cinnamon
Read the warning, when it applies and the studies cited
CASSIA - CINNAMOMUM AROMATICUM
Route of administration: Oral
Cautions and warnings
Condition of application: Appetite loss; Digestive disturbances/Indigestion; Traditional Chinese Medicine claims.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Products providing 1 g or more of branch bark, stem bark and/or trunk bark, per day
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (2)
- Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council; 2000.
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Gardner and McGuffin 2013; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
Contraindications
Applies to products providing 1 g or more of branch bark, stem bark and/or trunk bark, per day.
Do not use if you are pregnant (PPRC 2020; Brinker 2010; BHC 2006; Chen and Chen 2004; Blumenthal 2000, 1998).
Sources cited by Health Canada (6)
- BHC 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drugs - Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council; 2000.
- Blumenthal M, editor. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council in cooperation with Integrative Medicine Communications; 1998.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
- PPRC 2020: Pharmacopoeia of the People's Republic of China. Volume 1, English edition. Beijing (CN): The State Pharmacopoeia Commission of the People's Republic of China; 2020.
Condition of application: Traditional Chinese Medicine claims.
Do not use if you have excess heat, blood heat or deficiency, or yin-deficient fire (PPRC 2020; Bensky et al. 2004; Chen and Chen 2004).
Sources cited by Health Canada (3)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
- PPRC 2020: Pharmacopoeia of the People's Republic of China. Volume 1, English edition. Beijing (CN): The State Pharmacopoeia Commission of the People's Republic of China; 2020.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Gardner and McGuffin 2013; Blumenthal 2000; WHO 1999).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council; 2000.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Wonder Labs
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Berberine 500 mg : étiquette retirée du marché américain (Wonder Labs): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/99528874606-berberine-500-mg-wonder-labs, updated 26 September 2023.